Market accessOfficial
Estonia's medicines agency publishes 2026 statistical yearbook covering 2021–2025 market and use trends
🇪🇪 Ravimiamet · Tue 17 Nov 2026
Ravimiamet's yearbook reports semaglutide use rising from 2.9 to 21.6 DDD per 1,000 inhabitants daily and ADHD medicine use quadrupling, alongside a €559m wholesale market.
The Estonian State Agency of Medicines (Ravimiamet) has published its Statistical Yearbook 2026, an overview of the country's medicines market, medicines use and pharmacy activity from 2021 to 2025. The publication is a data resource and does not introduce regulatory requirements or safety actions.
Subscribe to keep reading
$4.99 / month
- Every article, analysis and opinion piece on VigiEye and CompePharma
- One subscription for both sites, cancel any time
or
Article written by VigiEye from the official source (Ravimiamet). AI-assisted; check the source before acting.
More Market access
All →
EEA Joint Committee adds six EU feed additive acts to Annex I of EEA Agreement
🇪🇺 EUR-Lex · Thu 19 Nov 2026
Health Canada flags Beckman Coulter DxC 500i software fault that may distort chemistry results
🇨🇦 Health Canada · Wed 18 Nov 2026
CMS moves Alimetry's Gastric Alimetry test to higher Medicare outpatient payment tier for 2027
Alimetry Inc. · Wed 18 Nov 2026
ANSM amends French generic groups directory in decision dated 12 November 2026
🇫🇷 ANSM · Wed 18 Nov 2026
Slovenia asks wholesalers to import estradiol 50 microgram patches amid supply disruption
🇸🇮 JAZMP · Wed 18 Nov 2026
SÚKL explains why Czech pharmacies may split repeat-prescription dispensing across days
🇨🇿 SÚKL · Wed 18 Nov 2026